Amphastar Pharma's President bids adieu [Seeking Alpha]
Amphastar Pharmaceuticals, Inc. (AMPH)
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amphastar.com/investor-relations
Company Research
Source: Seeking Alpha
Amphastar Pharmaceuticals (NASDAQ:AMPHannouncesDr. Jack Y. Zhang, CEO, Chief Scientific Officer and a member of the Board of Directors, has assumed the role and responsibilities of President, effective April 10.Mr. Zhang, co-founded Amphastar in 1996 and has served as CEO since inception.The Company is developing multiple pipeline products for injectable and intranasal dosage forms, including a new drug application for intranasal naloxone.
Show less
Read more
Impact Snapshot
Event Time:
AMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMPH alerts
High impacting Amphastar Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AMPH
News
- Why Amphastar (AMPH) is Poised to Beat Earnings Estimates Again [Yahoo! Finance]Yahoo! Finance
- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $71.00 price target on the stock.MarketBeat
- BetterInvesting™ Magazine Update on Amphastar Pharmaceuticals Inc. and Medtronic PLCPR Newswire
- With EPS Growth And More, Amphastar Pharmaceuticals (NASDAQ:AMPH) Makes An Interesting Case [Yahoo! Finance]Yahoo! Finance
- Hyaluronidase Market is Set to Grow at Staggering CAGR of 9.3% to Reach US$ 1,896.8 Million By 2032 | Astute Analytica [Yahoo! Finance]Yahoo! Finance
AMPH
Earnings
- 5/8/24 - Beat
AMPH
Sec Filings
- 6/28/24 - Form 4
- 6/27/24 - Form 144
- 6/11/24 - Form 4
- AMPH's page on the SEC website